Congress Takes Aim at Reducing the Cost of Medicine

Published date04 May 2021
Subject MatterFDA,FD&C Act,Pharmaceutical Industry,Prescription Drugs,Biosimilars,Biologics,Department of Health and Human Services (HHS)
AuthorSpencer J. Johnson
Law FirmRothwell, Figg, Ernst & Manbeck, P.C.

To continue reading

Request your trial

VLEX uses login cookies to provide you with a better browsing experience. If you click on 'Accept' or continue browsing this site we consider that you accept our cookie policy. ACCEPT